NCT04622618View on ClinicalTrials.gov

Optimal Dosing of Preoperative Gabapentin for Prevention of Postoperative Nausea and Vomiting

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

January 20, 2021

Study Completion Date

February 15, 2021

Conditions
Nausea, PostoperativeVomiting, PostoperativePain, Postoperative
Interventions
DRUG

Gabapentin

Anticonvulsant, Antiemetic, Analgesic

Trial Locations (2)

11591

AinShams University, Faculty of medicine, Cairo

Unknown

AinShams University, Faculty of medicine, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04622618 - Optimal Dosing of Preoperative Gabapentin for Prevention of Postoperative Nausea and Vomiting | Biotech Hunter | Biotech Hunter